Cataract, Retinal Detachment, and Macular Degeneration Notes

Cataract

  • Clinical Manifestations
    • Painless, blurry vision.
    • Sensitivity to glare.
    • Reduced visual acuity.
    • Myopic shift, astigmatism, diplopia (double vision), and color shifts including brunescens (color value to yellow-brown).
  • Diagnostic Findings
    • Decreased visual acuity.
    • Opacity of the lens by ophthalmoscope, slit-lamp, or inspection.
  • Surgical Management
    • Surgery is not needed if reduced vision does not interfere with normal activities.
    • Surgery is performed on an outpatient basis with local anesthesia.
    • Surgery usually takes less than 1 hour, and patients are discharged soon afterward.
    • Complications are rare but may be significant.
  • Types of Cataract Surgery
    • Intracapsular cataract extraction (ICCE):
      • Removes the entire lens.
      • Rarely done today.
    • Extracapsular cataract extraction (ECCE):
      • Maintains the posterior capsule of the lens.
      • Reduces potential postoperative complications.
    • Phacoemulsification:
      • An ECCE that uses an ultrasonic device to suction the lens out through a tube.
      • The incision is smaller than with standard ECCE.
    • Lens replacement:
      • After removal of the lens by ICE or ECCE, the surgeon inserts an intraocular lens implant (IOL).
      • This eliminates the need for aphakic lenses; however, the patient may still require glasses.
  • Nursing Management
    • Preoperative care:
      • Usual preoperative care for ambulatory surgery.
      • Dilating eye drops or other medications as ordered.
    • Postoperative care:
      • Patient teaching.
      • Provide written and verbal instructions.
      • Instruct patient to call physician immediately if:
        • Vision changes.
        • Continuous flashing lights appear.
        • Redness, swelling, or pain increase.
        • Type and amount of drainage increases.
        • Significant pain is not relieved by acetaminophen.

Retinal Detachment

  • Separation of the sensory retina and the RPE (retinal pigment epithelium).
  • Manifestations
    • Sensation of a shade or curtain coming across the vision of one eye.
    • Bright flashing lights.
    • Sudden onset of floaters (indicates bleeding).
  • Diagnostic Findings
    • Assess visual acuity.
    • Assessment of retina by indirect ophthalmoscope, slit-lamp, stereo fundus photography, and fluorescein angiography.
    • Tomography and ultrasound may also be used.
  • Common symptoms include floaters, flashes of light, and the sensation of a curtain falling.
  • Surgical Treatment
    • Scleral buckle:
      • A piece of silicone sponge, rubber, or semi-hard plastic is placed on the outside of the eye (the sclera, or the white of the eye).
      • The material is sewn to the eye to keep it in place.
      • The buckling element is usually left in place permanently.
    • Pars plana vitrectomy:
      • Removal of vitreous, locating the incisions at the pars plana.
      • Frequently used in combination with other procedures.
    • Pneumatic retinopexy:
      • Injected gas bubble, liquid, or oil is used to flatten the sensory retina against the RPE.
      • Postoperative positioning is critical.
  • Nursing Management
    • Patient teaching:
      • Eye surgery is most often done as an outpatient procedure, so patient education is vital.
      • Signs and symptoms of complications, especially increased IOP and infection.
    • Promote comfort.
    • Patient may need to lie in a special position with pneumatic retinopexy.

Macular Degeneration

  • Age-related macular degeneration (AMD).
  • The most common cause of vision loss in persons older than age 60.
  • Types
    • Dry or nonexudative type: most common, 85-90%.
      • Slow breakdown of the layers of the retinal with the appearance of drusen.
    • Wet type:
      • May have abrupt onset.
      • Proliferation of abnormal blood vessels growing under the retina - choroidal neovascularization (CNV).
  • Photodynamic Therapy for Slowing Progression of AMD
    • Light-sensitive verteporfin dye is injected into vessels. A laser then activates the dye, shutting down the vessels without damaging the retina.
    • The result is to slow or stabilize vision loss.
    • Patient must avoid exposure to sunlight or bright light for 5 days after treatment to avoid activation of dye in vessels near the surface of the skin.
  • Nursing Management
    • Patient teaching.
    • Supportive care.
    • Promote safety.
    • Recommendations to improve lighting and magnification devices.
    • Referral to vision center to improve/promote function.